|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM342716905 |
003 |
DE-627 |
005 |
20250303123002.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2022 xx |||||o 00| ||chi c |
024 |
7 |
|
|a 10.3760/cma.j.cn112140-20220506-00417
|2 doi
|
028 |
5 |
2 |
|a pubmed25n1142.xml
|
035 |
|
|
|a (DE-627)NLM342716905
|
035 |
|
|
|a (NLM)35750640
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a chi
|
100 |
1 |
|
|a Wang, X L
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Clinical characteristics and vaccination status of SARS-CoV-2 Omicron variant infected children
|
264 |
|
1 |
|c 2022
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Revised 16.02.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status Publisher
|
520 |
|
|
|a Objective: To investigate the clinical characteristics and vaccination status of SARS-CoV-2 Omicron variant infected children. Methods: A total of 105 children infected with Omicron variant admitted to Tianjin Haihe Hospital (designated referral hospital for SARS-CoV-2 infection in Tianjin) from January 8, 2022 to February 3 were included for a retrospective study. The cases were divided into pneumonia group and non-pneumonia group according to chest imaging. Based on the doses of inactivated SARS-CoV-2 vaccine, the children who completed SARS-CoV-2 antibody test within 3 days after hospitalization were divided into 2 dose group and<2 dose group.Rank sum test and Chi-square test were used for the comparison between the groups. Results: The age of these 105 children was 10 (8, 11) years on admission, 53 children were males and 52 were females. Eighty-seven cases (82.9%) had mild symptoms, 13 cases (12.4%) had common symptoms and 5 cases (4.8%) were asymptomatic. Ninety-one cases (86.7%) completed 2 doses vaccination. The clinical symptoms were characterized by cough (74 cases, 70.5%), fever (58 cases, 55.2%), sore or dry throat (34 cases, 32.4%), nasal congestion (28 cases, 26.7%), rhinorrhea (23 cases, 21.9%). None of the children received antivirals, steroids, immunosuppressant or oxygen therapy. Seventy-six cases(72.4%) received traditional Chinese medicine treatment. The pneumonia group had a higher rate of positive SARS-CoV-2 IgG within 1 day after admission (13/13 vs. 87.0% (80/92), χ2=42.81, P<0.001) than the non-pneumonia group. Among the 62 children who had serial SARS-CoV-2 antibody tests within 3 days after hospitalization, Compared to the<2 dose group, the 2 dose group had a higher rate of nucleic acid conversion within 16 days after onset and a higher rate of positive SARS-CoV-2 IgG 1 day after admission and 3 days after hospitalization (96.4% (54/56) vs. 4/6, 100.0% (56/56) vs. 2/6, 100.0% (56/56) vs. 3/6, all P<0.05). Conclusions: Most children infected with Omicron variant have mild symptoms, mainly respiratory infection symptoms. The proportion of SARS-CoV-2 antibody IgG positive in children who have received 2 doses of inactivated SARS-CoV-2 vaccines is higher,and the time of whose nucleic acid conversion may be shortened
|
650 |
|
4 |
|a English Abstract
|
650 |
|
4 |
|a Journal Article
|
700 |
1 |
|
|a Zhai, J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zou, Y X
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Zhonghua er ke za zhi = Chinese journal of pediatrics
|d 1960
|g 60(2022), 7 vom: 15. Juni, Seite 671-675
|w (DE-627)NLM136249191
|x 0578-1310
|7 nnas
|
773 |
1 |
8 |
|g volume:60
|g year:2022
|g number:7
|g day:15
|g month:06
|g pages:671-675
|
856 |
4 |
0 |
|u http://dx.doi.org/10.3760/cma.j.cn112140-20220506-00417
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_39
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_50
|
912 |
|
|
|a GBV_ILN_61
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_72
|
912 |
|
|
|a GBV_ILN_120
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_227
|
912 |
|
|
|a GBV_ILN_244
|
912 |
|
|
|a GBV_ILN_285
|
912 |
|
|
|a GBV_ILN_294
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_665
|
912 |
|
|
|a GBV_ILN_813
|
951 |
|
|
|a AR
|
952 |
|
|
|d 60
|j 2022
|e 7
|b 15
|c 06
|h 671-675
|